American Society for Cytotechnology (ASCT) 2020 Annual Conference is organized by American Society for Cytotechnology (ASCT) and will be held from Aug 28 - 30, 2020 at Riviera Palm Springs Resort, Palm Springs, California, United States of America. Additional details will be posted as soon as information is available.

Taking Control of Your Diabetes (TCOYD) & MTC Conference is organized by Taking Control of Your Diabetes (TCOYD) and will be held on Sep 12, 2020 at Palm Springs, California, United States of America. Additional details will be posted as soon as information is available.

51st Environmental Mutagenesis and Genomics Society (EMGS) Annual Meeting is organized by Environmental Mutagenesis and Genomics Society (EMGS) and will be held from Sep 12 - 16, 2020 at Renaissance Palm Springs Hotel, Palm Springs, California, United States of America. Additional details will be posted as soon as they are available.

2020 International Conference on Forensic Nursing Science and Practice is organized by International Association of Forensic Nurses (IAFN) and will be held from Sep 23 - 26, 2020 at Palm Springs, California, United States of America. Additional details will be posted as soon as they are available.

Practical Issues in Urologic Pathology 40 New Cases! is organized by United States and Canadian Academy of Pathology (USCAP) and will be held from Sep 23 - 25, 2020 at USCAP West, Palm Springs, California, United States of America. Accreditation: The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The United States and Canadian Academy of Pathology designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Continuing Certification (CC). Physicians can earn a maximum of 15 SAM credit hours. Course Description Specimens represented by prostate needle core biopsies, transurethral resection of prostate (TURP), radical prostatectomy, kidney biopsies, nephrectomy (radical or partial), bladder biopsies, cystectomy (radical or partial), cystoprostatectomy, testicular biopsies or orchiectomy are frequently handled by pathology residents/fellows, general surgical pathologists and/or urologic pathologists in academic institutions and private practices. These specimens are associated with potential diagnostic challenges and risks in day-to-day practice. This experienced faculty has selected exemplary cases from their expert consultation files (and routine in-house cases) that illustrate recurrent professional practice gaps in urologic pathology. Through intimate mentoring, you will learn how to approach them, make accurate diagnoses, and avoid traps and pitfalls that could cause diagnostic error. The course is pragmatic, clinically-oriented and stimulating. It will focus on these issues: • Benign tumor-like lesions of the prostate are often over-diagnosed as prostate cancer or atypical small acinar proliferations • Secondary tumors involving the prostate are frequently misdiagnosed as prostate cancer • Histological variants of prostate cancer with important clinical significance are under-recognized • Therapy-related changes in benign glands and prostate cancer are frequently missed • Extra-prostatic extension in prostate needle core biopsies is frequently missed • Recently described renal carcinomas are not well-appreciated • Secondary tumors involving the kidney are occasionally misinterpreted as primary tumors • Some variants of urothelial carcinoma are under-recognized • Benign entities that mimic urothelial carcinoma are frequently misdiagnosed • Testicular tumors still continue to pose diagnostic challenges Course Objectives: • Recognize the most common benign mimickers of prostate cancer, identify therapy-related changes in the prostate and be aware of traps and pitfalls • Identify secondary tumors involving the prostate, tumors arising from the prostatic urethra, and histologic variants of prostate cancer • Update pathologists on newly-described entities in renal neoplasia, including guidelines for using immunohistochemistry in the work-up of renal tumors • Develop a systematic approach to the diagnosis of bladder lesions, primary and secondary bladder tumors, benign mimickers of malignancy and staging criteria • Introduce the new concepts and entities presented in the WHO 2016 Classification of Testicular Tumors including differential diagnoses, morphologic mimics and prognostic significance Additional details will be posted as soon as they are available.

Hematopathology Tasting Menu: A Sampling of Delightful Diagnostic Challenges Course is organized by United States and Canadian Academy of Pathology (USCAP) and will be held from Oct 14 - 16, 2020 at USCAP Interactive Center, Palm Springs, California, United States of America. Target Audience: The target audience is general pathologists who diagnose bone marrow and lymphoid lesions, practicing hematopathologists and hematopathology fellows. Accreditation: • The United States and Canadian Academy of Pathology designates this live activity for a maximum of 18 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. • Physicians can earn a maximum of 18 SAM credit hours. Course Description: The most recent (2016) WHO classification of hematologic neoplasms delineates specific diagnostic criteria for well-defined neoplastic entities. However, pathologists who diagnose bone marrow biopsies and lymphoid proliferations often face challenges that are not directly addressed by the WHO system or represent reactive conditions that may mimic hematologic malignancies. These include atypical morphologic features, unexpected immunostaining patterns, and discordant genetic features in neoplastic entities. Pathologists often have difficulties applying the WHO criteria if they are not fully concordant with the expected patterns and/or if they are relatively new entities with which pathologists may be unfamiliar. Moreover, there is inherent subjectivity in interpreting morphologic findings and even the results of ancillary testing. The literature contains reports about the intrinsic interobserver variability in making hematopathology diagnoses and pitfalls when applying established criteria. This course aims to bridge the practice gaps between the 'ideal world' WHO classification system and the 'real world' of hematopathology diagnosis by presenting challenging case examples. These cases will illustrate how to interpret correctly and apply morphologic criteria in diagnosing hematologic neoplasms (including newer entities), how to avoid diagnosing malignancy in benign mimics, and how appropriately to integrate the results of ancillary testing with the morphology, particularly when there are discordant or unexpected results. We will provide participants with guidelines on how practically to approach such cases and avoid misdiagnosis, thereby improving their performance in daily practice. Course Objectives: • Use ancillary testing appropriately to diagnose lymphoid neoplasms correctly • Recognize reactive mimics of hematopoietic neoplasms • Use morphologic clues effectively to guide the workup of myeloid neoplasms • Apply current (2016) WHO Classification criteria to the diagnosis of hematologic neoplasms, emphasizing newer entities Additional details will be posted as soon as information is available.

American Institute of Oral Biology (AIOB) 2020 Annual Meeting is organized by American Institute of Oral Biology (AIOB) and will be held from Oct 23 - 25, 2020 at Hilton Palm Springs, Palm Springs, California, United States of America. Accreditation: The AIOB is a Continuing Education Registered Provider with the Dental Board of California and will issue at the most 24 units of continuing education credits. Additional details will be posted as soon as information is available.

Dermatopathology in the Desert: Dodging Bullets in the Dermatopathology Wilderness is organized by United States and Canadian Academy of Pathology (USCAP) and will be held from Nov 01 - 03, 2020 at USCAP Interactive Center, Palm Springs, California, United States of America. Accreditation: The United States and Canadian Academy of Pathology designates this live activity for a maximum of 15.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians can earn a maximum of 15.75 SAM/Part II credit hours. Course Description: Differentiating neoplastic from non-neoplastic disorders is one of the most difficult diagnostic challenges in pathology. Accurate diagnosis is paramount to initiate the appropriate treatment. It requires specific skills which often include at least some degree of clinical knowledge, awareness of the broad morphologic range and familiarity with ancillary tests. Errors in the interpretation of skin biopsies, especially in relation to melanocytic tumours, are among the most frequent causes for litigation in surgical biopsy and can lead to unfavorable patient outcomes. There are numerous pitfalls that diagnostic pathologists need to be aware of, including lack of relevant clinical information, sampling error and the wide morphologic spectrum of both inflammatory and neoplastic disorder, often showing overlapping findings and only subtle differentiating features. This special course will elevate your knowledge and polish your diagnostic skills as you interact with experts in a uniquely intimate mentoring environment. Course Objectives: • Understand the wide morphologic spectrum of cutaneous tumors and associated diagnostic challenges • Learn about recent developments in dermatopathology • Learn how to integrate clinical information and ancillary tests to achieve a better and more precise diagnosis • Understand the appropriate use and limitations of immunofluorescence testing in dermatopathology

Head and Neck Pathology: Top to Bottom Training to Avoid the Ups and Downs is organized by United States and Canadian Academy of Pathology (USCAP) and will be held from Dec 12 - 13, 2020 at USCAP Interactive Learning Center, Palm Springs, California, United States of America. Accreditation: The United States and Canadian Academy of Pathology designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians can earn a maximum of 14 SAM/Part II credit hours. Course Description: Head and neck pathology represents a significant portion of surgical pathology practice. Studies have shown this area to be particularly treacherous to community pathologists with up to 53% of diagnoses changed (including 7% with major changes) upon second review at tertiary care hospitals (Kronz and Westra, Curr Opin Otolaryngol Head Neck Surgery 2005; 13:81-4). In recent years there have been numerous developments in head and neck pathology, further complicating this inherent difficulty. Novel entities have been described, pathognomonic molecular alterations have been uncovered, and major shifts in diagnostic classification schemes have been proposed. Many of these concepts were incorporated into the newest editions of the WHO Classifications for Head and Neck and Endocrine Tumors, both of which were published recently. Taken together, it is difficult for pathologists to stay current and maintain proficiency in head and neck pathology without supplemental training and education. This course is a terrific opportunity to refine your diagnostic skills in a uniquely personal mentoring environment with energetic pathologists whose keen eyes, diagnostic acumen, and a modern approach will create an indelible impression. This course is designed for general pathologists, practicing surgical pathologists, senior residents and pathologists with special interest in head and neck pathology. Course Objectives: • Recognize the updated WHO terminology of salivary gland carcinoma • Develop a diagnostic approach to the encapsulated follicular-patterned thyroid nodule • Describe the algorithmic approach to HPV testing in a head and neck cancer • Develop a diagnostic approach to the “small round blue cell” sinonasal tumor • Recognize the appropriate differential diagnosis for sinonasal glandular proliferations

SGS 47th Annual Scientific Meeting is organized by Society of Gynecologic Surgeons (SGS) and will be held from Mar 21 - 24, 2021 at The Westin Mission Hills Golf Resort & Spa, Palm Springs, California, United States of America. Additional details will be posted as soon as information is available.